Atlas Venture Fund XI, L.P.

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$26.74M
Insider Sells Quantity
15
Insider Sells Sum
$43.22M

Insider Activity of Atlas Venture Fund XI, L.P.

According to the SEC Form 4 filings, Atlas Venture Fund XI, L.P., being in a position of

  1. 10 percent owner at Dyne Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1818779 shares for $42.83M,
    over all time since 2024-02-15, has bought 0 shares, and sold 1818779 shares for $42.83M.

The largest purchase of all time was on 2019-06-24 and amounted to 540000 shares of Akero Therapeutics, Inc. for $8.64M.

The largest sale of all time was on 2024-02-27 and amounted to 368699 shares of Dyne Therapeutics, Inc. for $9M.

Biography of Atlas Venture Fund XI, L.P.

No biography is available at this moment.

2024-02-28SaleDyne Therapeutics, Inc.
DYN
10 percent owner
190,920
0.1522%
$24.84$4.74M+25.74%
2024-02-27SaleDyne Therapeutics, Inc.
DYN
10 percent owner
368,699
0.2889%
$24.41$9M+27.68%
2024-02-26SaleDyne Therapeutics, Inc.
DYN
10 percent owner
248,219
0.189%
$23.72$5.89M+30.32%
2024-02-23SaleDyne Therapeutics, Inc.
DYN
10 percent owner
196,928
0.1435%
$22.70$4.47M+37.12%
2024-02-22SaleDyne Therapeutics, Inc.
DYN
10 percent owner
119,360
0.0868%
$22.66$2.7M+39.38%
2024-02-21SaleDyne Therapeutics, Inc.
DYN
10 percent owner
184,501
0.1337%
$22.57$4.16M+38.45%
2024-02-20SaleDyne Therapeutics, Inc.
DYN
10 percent owner
169,539
0.1237%
$22.72$3.85M+37.25%
2024-02-16SaleDyne Therapeutics, Inc.
DYN
10 percent owner
162,707
0.1209%
$23.14$3.77M+36.19%
2024-02-15SaleDyne Therapeutics, Inc.
DYN
10 percent owner
177,906
0.1364%
$23.89$4.25M+32.06%
2024-02-08SaleXilio Therapeutics, Inc.
XLO
10 percent owner
1,000
0.0034%
$0.64$640+56.33%
2024-01-12SaleXilio Therapeutics, Inc.
XLO
10 percent owner
2,100
0.0088%
$0.83$1,743+24.86%
2024-01-11SaleXilio Therapeutics, Inc.
XLO
10 percent owner
2,135
0.0083%
$0.87$1,857+9.6%
2022-09-19PurchaseThird Harmonic Bio, Inc.
THRD
10 percent owner
300,000
0.887%
$17.00$5.1M-70.12%
2021-12-14SaleIkena Oncology, Inc.
IKNA
10 percent owner
5,959
0.0217%
$14.00$83,426-63.59%
2021-12-13SaleIkena Oncology, Inc.
IKNA
10 percent owner
8,330
0.0307%
$14.64$121,951-64.74%
2021-12-10SaleIkena Oncology, Inc.
IKNA
10 percent owner
11,989
0.0457%
$15.03$180,195-64.33%
2021-10-26PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
187,500
0.6839%
$16.00$3M-76.08%
2021-06-01PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
1.24M
1.6574%
$6.44$8M-14.32%
2021-03-30PurchaseIkena Oncology, Inc.
IKNA
10 percent owner
125,000
2.0291%
$16.00$2M-49.34%
2021-02-01PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
1.48M
–
$0$0
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.